Autonomix Secures Principal Investigators and Completes Clinical Training for First Human Study
February 22, 2024 08:00 ET
|
Autonomix Medical, Inc.
Proof-of-concept (PoC) human clinical trial targeting multi-billion-dollar pancreatic cancer market through transvascular RF ablation Company expects to commence patient enrollment imminently...
Sécurisation de l’approvisionnement en plasma du Canada
August 06, 2019 13:00 ET
|
Société canadienne du sang
OTTAWA, 06 août 2019 (GLOBE NEWSWIRE) -- La Société canadienne du sang a le plaisir d’annoncer qu’avec le soutien de ses bailleurs de fonds, elle a entrepris d’augmenter la quantité de plasma...
Securing Canada’s plasma supply
August 06, 2019 13:00 ET
|
Canadian Blood Services
OTTAWA, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Canadian Blood Services is pleased to announce that with the support of funding governments, plans are now underway to increase plasma collection with three...
PROVECTUS BIOPHARMACEUTICALS PROVIDES DRUG DEVELOPMENT UPDATE FOR IMMUNO-DERMATOLOGY ASSET PH-10
November 14, 2018 07:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided an update on the Company’s small molecule clinical development program for its investigational...
GrowLife, Inc. Announces 4x Increase in Production Capacity from 15 to 70 Plants Using its Proprietary Vertical Grow Room
July 18, 2018 09:00 ET
|
GrowLife, Inc.
KIRKLAND, Wash., July 18, 2018 (GLOBE NEWSWIRE) -- GrowLife, Inc. (OTCQB:PHOT), one of the nation’s most recognized indoor cultivation product and service providers, today announced preliminary test...